ammy dez
ammy dez

ammy dez

      |      

Подписчики

Therapeutic Drug Monitoring Market – Research Provides In-Depth Detailed Analysis of Trends and Forecast

Therapeutic Drug Monitoring Market – Research Provides In-Depth Detailed Analysis of Trends and Forecast

Introduction to Therapeutic Drug Monitoring Therapeutic drug monitoring (TDM) is a process of measuring the concentration of a drug in a patient's bloodstream in order to ensure that the medication is being taken at the correct dose and is having the desired effect. This process involves measuring the concentration of the drug in a blood sample taken from the patient, often at regular intervals, and then comparing this concentration to a range that is considered therapeutic. If the concentration of the drug is outside of this range, the dose of the drug can be adjusted accordingly to ensure that the patient is receiving the correct amount of medication. TDM can be used to monitor the effectiveness of a medication, to assess potential side effects, and to identify any potential drug interactions. Additionally, TDM can be used to optimize a patient's dosing schedule to ensure that they are taking the correct amount of medication at the right time. TDM can also be used to identify drug abuse or misuse, as well as to detect drug poisoning. Overview of the Therapeutic Drug Monitoring The global therapeutic drug monitoring market is projected to reach...

Global Cancer Diagnostics Market - Segmentation, Geographical Analysis & Major Key Players

Global Cancer Diagnostics Market - Segmentation, Geographical Analysis & Major Key Players

The Global Cancer Diagnostics Market in terms of revenue was estimated to be worth $17.2 billion in 2021 and is poised to reach $26.6 billion by 2026, growing at a CAGR of 11.5% from 2021 to 2026. Growth of the market is driven mainly by increasing incidence of cancer and growth in the number of private diagnostic laboratories. Key Market Players: Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La Roche AG (Switzerland), QIAGEN N.V. (Netherlands), Fujifilm Corporation (Japan), Aglient Technologies (US) and Thermo Fisher Scientific Inc. (US) etc. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121 Breast Cancer Diagnostics Market Growth Dynamics Drivers: Growth in the number of private diagnostic centers The number of private diagnostic centers is increasing across the globe as there is a rising demand for diagnostic imaging procedures and a growing burden on public hospitals due to the limited number of imaging modalities at their disposal. In January 2021, FUJIFILM Corporation opened NURA, a medical screening center focusing on cancer screening in Bangalore, India. This medical screening center is operated by FUJIFILM DKH LLP (FUJIFILM DKH) and Dr. Kutty’s Healthcare (DKH). FUJIFILM DKH LLP (FUJIFILM DKH) is a joint venture of FUJIFILM and...

Global Regenerative Medicine Market to Hit Value of USD 40.6 billion by 2027, with CAGR of 27.2%

Global Regenerative Medicine Market to Hit Value of USD 40.6 billion by 2027, with CAGR of 27.2%

The Regenerative Medicine Market is projected to reach USD 40.6 billion by 2027, at a CAGR of 27.2% during the forecast period. Market growth is driven by the availability of funding and rising investments in R&D, increasing clinical trials for stem cell and CAR-T cell therapies, and rising advancements in tissue-engineered products. However, the high treatment cost of RM therapies and issues associated with commercialization and regulatory compliance factors are expected to restrain the market growth during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579 Key Players: AG (Switzerland), Biogen (US), Sarepta Therapeutics, Inc. (US), Gilead Sciences, Inc. (US), Amgen, Inc. (US), Smith & Nephew plc (UK), MEDIPOST Co., Ltd. (South Korea), JCR Pharmaceuticals Co., Ltd (Japan), Takeda Pharmaceutical Company (Japan), CORESTEM Inc (South Korea), Vericel Corporation (US), MiMedx (US), Organogenesis Inc. (US), Medtronic plc (US), Orthocell Ltd. (Australia), Mesoblast Ltd (Australia), BioRestorative Therapies, Inc (US), Pluri Inc. (Israel), Tegoscience (South Korea), Anterogen Co., Ltd. (South Korea), bluebird bio, Inc. (US), APAC Biotech (India), Shenzhen SiBiono Genetech Co., Ltd. (China), Aspect Biosystems (Canada), and Athersys, Inc. (US). Gene Therapy Industry Dynamics Drivers: Availability of funding and rising investments in R&D The rising need for improved therapies for cancer, diabetes, skin...

Laboratory Information Management System Market size, share, Growth and Forecasts to 2026

Laboratory Information Management System Market size, share, Growth and Forecasts to 2026

The Global Laboratory Information Management System market is projected to reach USD 2.1 billion by 2026, at a CAGR of 13.2%. The growth of this market is attributed to the increasing use of LIMS to comply with stringent regulatory requirements, rising need for the adoption of LIMS, technological advancements in LIMS offerings, increasing R&D expenditure in different industries, and growing adoption of cloud-based LIMS. Key Players: LabWare (US), LabVantage Solutions (US), Thermo Fisher Scientific (US), Abbott Informatics (US), Agilent Technologies Inc. (US), LabLynx, Inc. (US), Dassault Systèmes (France), Labworks LLC (US), Autoscribe Informatics (US), and Accelerated Technology Laboratories (ATL). Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250610373 Drivers: Growing use of LIMS to comply with stringent regulatory requirements In various countries, pharmaceutical and biotechnology companies face immense pressure to comply with strict regulatory guidelines for preclinical and clinical testing before launching new drugs into the market. For instance, regulatory requirements such as 21 CFR Part 11 and Clinical Laboratory Improvement Amendments (CLIA) in the pharmaceutical and biotech industries include documentation and audit trails from research & development and testing to production and quality control. In addition to these regulations, guidelines regarding appropriate labelling and advertising are also required to be...